- £1.23bn
- £2.43bn
- £150.40m
- 30
- 51
- 76
- 51
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 11.72 | ||
| PEG Ratio (f) | 3.22 | ||
| EPS Growth (f) | 3.78% | ||
| Dividend Yield (f) | 8.12% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.81 | ||
| Price to Tang. Book | 0.81 | ||
| Price to Free Cashflow | 12.67 | ||
| Price to Sales | 8.07 | ||
| EV to EBITDA | 19.42 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.03% | ||
| Return on Equity | -10.15% | ||
| Operating Margin | -110.03% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 102.4 | 111.5 | 120.8 | 136.9 | 150.4 | 148.16 | 154.68 | 11.8% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -46.22 | -6.75 | +32.5 | +29.18 | n/a | n/a | +3.78 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests and treatments in the community. The Company is a long-term property partner to more than 600 medical centers. The Company owns and manages a portfolio of about 607 properties. Its subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, and others.
Directors
- Ed Smith NEC
- Jonathan Murphy CEO (49)
- Jayne Cottam CFO (46)
- Orla Ball SEC (50)
- Sam Barrell NED
- Emma Cariaga NED
- Noel Gordon NED
- Jonathan Davies NID
- Louise Fowler NID
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- December 10th, 2014
- Public Since
- January 28th, 2015
- No. of Employees
- 74
- Sector
- Residential & Commercial REITs
- Industry
- Financials
- Exchange
London Stock Exchange- Shares in Issue
- 2,989,454,390
- Address
- 3 Barrington Road, ALTRINCHAM, WA14 1GY
- Web
- https://www.assuraplc.com/
- Phone
- +44 1615524506
- Contact
- David Purcell
- Auditors
- Ernst & Young LLP
Latest News for AGR
Upcoming Events for AGR
Full Year 2024 Assura PLC Earnings Release
Assura PLC Annual Shareholders Meeting
Similar to AGR
abrdn Property Income Trust
London Stock Exchange
Aew UK Reit
London Stock Exchange
Alina Holdings
London Stock Exchange
Alternative Income REIT
London Stock Exchange
Balanced Commercial Property Trust
London Stock Exchange
FAQ
As of Today at 19:03 UTC, shares in Assura are trading at 41.20p. This share price information is delayed by 15 minutes.
Shares in Assura last closed at 41.20p and the price had moved by -21.22% over the past 365 days. In terms of relative price strength the Assura share price has underperformed the FTSE All Share Index by -22.58% over the past year.
The overall consensus recommendation for Assura is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Assura dividend yield is 6.59% based on the trailing twelve month period.
Last year, Assura paid a total dividend of £0.03, and it currently has a trailing dividend yield of 6.59%. We do not have any data on when Assura is to next pay dividends.
We do not have data on when Assura is to next pay dividends. The historic dividend yield on Assura shares is currently 6.59%.
To buy shares in Assura you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 41.20p, shares in Assura had a market capitalisation of £1.23bn.
Here are the trading details for Assura:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: AGR
Based on an overall assessment of its quality, value and momentum Assura is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Assura is 51.83p. That is 25.8% above the last closing price of 41.20p.
Analysts covering Assura currently have a consensus Earnings Per Share (EPS) forecast of £0.03 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Assura. Over the past six months, its share price has underperformed the FTSE All Share Index by -3.79%.
As of the last closing price of 41.20p, shares in Assura were trading -6.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Assura PE ratio based on its reported earnings over the past 12 months is 11.72. The shares last closed at 41.20p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Assura's management team is headed by:
- Ed Smith - NEC
- Jonathan Murphy - CEO
- Jayne Cottam - CFO
- Orla Ball - SEC
- Sam Barrell - NED
- Emma Cariaga - NED
- Noel Gordon - NED
- Jonathan Davies - NID
- Louise Fowler - NID